Compass Therapeutics, Inc.

CMPX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jan 20, 2022 FORM 8-K
SC 13G Dec 30, 2021
8-K Dec 21, 2021 8-K
SC 13G/A Dec 17, 2021
424B5 Dec 15, 2021 424B5
424B5 Dec 15, 2021 424B5
4 Nov 18, 2021 FORM 4 SUBMISSION
4 Nov 18, 2021 FORM 4 SUBMISSION
10-Q Nov 12, 2021 10-Q
SC 13G Nov 12, 2021 SC 13G
SC 13D/A Nov 9, 2021 AMENDMENT NO. 2
4 Nov 8, 2021
4 Nov 8, 2021
8-K Nov 3, 2021 8-K
424B5 Nov 3, 2021 424B5
CERT Nov 1, 2021
424B5 Nov 1, 2021 424B5
8-A12B Nov 1, 2021 8-A12B
8-K Nov 1, 2021 8-K
8-K Oct 8, 2021 8-K
10-Q Aug 16, 2021 10-Q
8-K/A Aug 5, 2021 8-K/A
EFFECT Jul 20, 2021
CORRESP Jul 16, 2021
UPLOAD Jul 15, 2021
← Newer Page 11 of 15 · 359 filings Older →